A new Report by Delvens, titled "Cancer Diagnostics Market” offers a comprehensive analysis of the industry, which comprises insights on the Global analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global Cancer Diagnostics market size was estimated at USD 17.1 billion in 2023 and is projected to reach USD 44.4 billion in 2030 at a CAGR of 11.2% during the forecast period 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/cancer-diagnostics-market
North America to Dominate the Cancer Diagnostics Market
· The geographical region of North America is anticipated to make a significant contribution to the advancement of the cancer diagnostics market growth. Furthermore, due to the emergence of the unprecedented COVID-19 pandemic, the aforementioned region has also been observed to experience an adverse impact in terms of market growth.
· The Union for International Cancer Controls (UICC) posits, in its latest report, that there has been an unmistakable and noteworthy reduction in the rates of cancer diagnostics in the United States during the course of the pandemic.
Competitive Landscape: Cancer Diagnostics Market
· Abbott
· DiagnoCure Inc.
· Thermo Fisher Scientific
· Illumina, Inc.
· QIAGEN
· F. Hoffmann-La Roche Ltd
· Agilent Technologies, Inc.
· Quest Diagnostics Incorporated.
· Merck KGaA,
· Hologic, Inc.
· BD.
· GSK plc.
· Novartis AG
· Bristol-Myers Squibb Company
· Lilly
· Pfizer, Inc and More
Recent Developments
· In 2022, the company entered into a distribution agreement for one of its products, HemeScreen, with a major distribution partner in the United States.HemeScreen is a diagnostic test that helps in the detection of hematologic malignancies, which are cancers that affect the blood, bone marrow, and lymph nodes. The distribution agreement is part of Precipio's strategy to expand the distribution of HemeScreen.
· In November 2021, Siemens Healthineers introduced Magnetom Free. Star, is a cost-effective whole-body MRI scanner, designed to enable significantly better access to magnetic resonance imaging globally.
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/cancer-diagnostics-market
The proliferation of programs aimed at heightening public consciousness about malignant tumor screening across various organizations has emerged as a crucial catalyst driving the escalating demand for diagnostic products worldwide. A plethora of nations have implemented diverse measures to enhance early screening and extend support to patients. Notably, the Indian government has launched the Prime Minister's National Relief Fund and Ayushman Bharat to provide treatment assistance to patients.
This, in turn, serves as a propellant for augmenting market growth. Furthermore, there has been a remarkable upsurge in the number of testing kit launches, which have bolstered the market's expansion. A case in point is the ipsogen JAK2 DX reagent unveiled by Sysmex Corporation in 2020. This gene testing kit quantitatively measures the JAK2V617F mutation, which is extensively employed for screening blood cancers. Additionally, the product has garnered health insurance coverage, becoming the first diagnostic product in Japan to receive such coverage in 2020. Hence, this aspect contributes significantly to the market's growth trajectory.
The Cancer Diagnostics Market is segmented into various segments such as product, application, By end-use and region:
Based on Product
· Consumables
· Antibodies
o Kits & Reagents
o Probes
o Other Consumables
Based on Application
· Breast Cancer
· Colorectal Cancer
· Cervical Cancer
· Lung Cancer
· Prostate Cancer
· Skin Cancer
· Blood Cancer
· Kidney Cancer
· Liver Cancer
· Pancreatic Cancer
· Ovarian Cancer
· Others
Based on End Use
· Hospitals and Clinics
· Diagnostic Laboratories
· Diagnostic Imaging Centers
· Research Institutes
Access Full Report: https://www.delvens.com/report/cancer-diagnostics-market
In addition to the market data for the Cancer Diagnostics Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Frequently Asked Questions
· What are the years considered to study Cancer Diagnostics Market?
· What is the compound annual growth rate (CAGR) of the Cancer Diagnostics Market?
· Which region holds the largest market share in Cancer Diagnostics Market?
· Which region is the fastest growing in Cancer Diagnostics Market?
· Who are the major players in Cancer Diagnostics Market?
More Reports from Delvens:
Energy based Medical Aesthetics Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
